Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 23 July 2020




Free trade agreement with MRA in the best interest of European pharma, says new research
23 July 2020

New research published today outlines the importance of a free trade agreement with a mutual recognition agreement for... Read more

EFPIA Statement on EU4Health Budget cuts
23 July 2020

The devastating effects on people and societies of COVID-19 has underlined that investment in our health systems is... Read more




Elephants, fairness, and magic formulas in drug pricing (Guest blog)
23 July 2020 - Alexander Roediger

About price, access and affordability Read more


We published


Key Trade Data Points on the EU27 Pharmaceutical Supply Chain
09 July 2020 (Publications)

In 2019, 86.2% of EU27 imports of Human Medicinal Products came from Europe Read more

The pharmaceutical industry: a key asset to medical progress and the European economy
30 June 2020 (Publications)

Our annual statistics leaflet Read more

The root causes of unavailability and delay to innovative medicines
01 July 2020 (Publications)

Analysis developed with the support of Charles Rivers Associates (CRA) Read more


What we are reading


Reviewing orphan drugs law: A tough equation
On 06 July 2020 (EurActiv)

The Orphan Regulation was introduced in 2000 and its main objective was to address the challenge of regulating medicines... Read more